BARLOW; Carrolee

Patent Applications and Registrations

Patent applications and USPTO patent grants for BARLOW; Carrolee.The latest application filed is for "crispr-based downregulation of alpha-synuclein expression as a novel parkinson's disease therapeutic".

Company Profile

5.6.33

BARLOW; Carrolee - Mountain View CA
BARLOW; Carrolee - Sunnyvale CA
Barlow; Carrolee - Solana Beach CA
Barlow; Carrolee - Del Mar CA
Barlow; Carrolee - San Diego CA
Barlow, Carrolee - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crispr-based Downregulation Of Alpha-synuclein Expression As A Novel Parkinson's Disease Therapeutic App 20210047627 - SCHULE; Birgitt ; et al.	2021-02-18
Methods And Compositions For Evaluation And Treatment Of Synucleinopathies App 20200165358 - BARLOW; Carrolee ; et al.	2020-05-28
Methods For Evaluation Of Treatment And Progression Of Neurological Disorders App 20190358349 - BARLOW; Carrolee	2019-11-28
Refining Diagnosis And Treatment Of Complex Multi-symptom Neurological Disorders App 20190085394 - Langston; J. William ; et al.	2019-03-21
Neurogenesis By Muscarinic Receptor Modulation App 20110319386 - Barlow; Carrolee ; et al.	2011-12-29
Neurogenesis By Modulating Angiotensin App 20110269717 - BARLOW; Carrolee ; et al.	2011-11-03
Combinations containing a 4-acylaminopyridine derivative Grant 7,998,971 - Barlow , et al. August 16, 2	2011-08-16
Modulation of neurogenesis by PDE inhibition Grant 7,985,756 - Barlow , et al. July 26, 2	2011-07-26
Modulation Of Neurogenesis With Gaba Agents And Gaba Analogs App 20110046090 - BARLOW; Carrolee ; et al.	2011-02-24
Neurogenesis by modulating angiotensin Grant 7,858,611 - Barlow , et al. December 28, 2	2010-12-28
Modulation Of Neurogenesis By Nootropic Agents App 20100216734 - Barlow; Carrolee ; et al.	2010-08-26
Modulation Of Neurogenesis Using D-cycloserine Combinations App 20100216805 - Barlow; Carrolee ; et al.	2010-08-26
Modulation Of Neurogenesis By Ppar Agents App 20100184806 - Barlow; Carrolee ; et al.	2010-07-22
Neurogenesis By Muscarinic Receptor Modulation App 20100120842 - Barlow; Carrolee ; et al.	2010-05-13
5 HT receptor mediated neurogenesis Grant 7,678,808 - Barlow , et al. March 16, 2	2010-03-16
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs Grant 7,678,363 - Barlow , et al. March 16, 2	2010-03-16
5 Ht Receptor Mediated Neurogenesis App 20100009983 - Barlow; Carrolee ; et al.	2010-01-14
5 Ht Receptor Mediated Neurogenesis App 20090325949 - Barlow; Carrolee ; et al.	2009-12-31
Mcc-257 Modulation Of Neurogenesis App 20090239834 - Barlow; Carrolee ; et al.	2009-09-24
Aliskiren Modulation Of Neurogenesis App 20090197823 - Barlow; Carrolee ; et al.	2009-08-06
4-acylaminopyridine Derivative Mediated Neurogenesis App 20090088449 - Barlow; Carrolee	2009-04-02
Microelectronic arrays for cell-based functional genomics/high throughput phenotyping by electrokinetic assembly Grant 7,510,637 - Barlow , et al. March 31, 2	2009-03-31
Modulation of Neurogenesis with Biguanides and GSK3-beta Agents App 20080188457 - Barlow; Carrolee ; et al.	2008-08-07
Modulation Of Neurogenesis With Use of Modafinil App 20080171750 - Barlow; Carrolee ; et al.	2008-07-17
Modulation of Neurogenesis By Melatoninergic Agents App 20080167363 - Barlow; Carrolee ; et al.	2008-07-10
Melanocortin Receptor Mediated Modulation Of Neurogenesis App 20080108574 - Barlow; Carrolee ; et al.	2008-05-08
HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS App 20080103105 - Barlow; Carrolee ; et al.	2008-05-01
Ppar Mediated Modulation Of Neurogenesis App 20080103165 - Barlow; Carrolee ; et al.	2008-05-01
Combinations Containing A 4-acylaminopyridine Derivative App 20080064671 - Barlow; Carrolee ; et al.	2008-03-13
5 Ht Receptor Mediated Neurogenesis App 20070270449 - Barlow; Carrolee ; et al.	2007-11-22
Modulation Of Neurogenesis By Nootropic Agents App 20070244143 - Barlow; Carrolee ; et al.	2007-10-18
Modulation Of Neurogenesis By Pde Inhibition App 20070208029 - Barlow; Carrolee ; et al.	2007-09-06
Gaba Receptor Mediated Modulation Of Neurogenesis App 20070112017 - Barlow; Carrolee ; et al.	2007-05-17
MODULATION OF NEUORGENESIS BY HDac INHIBITION App 20070078083 - Barlow; Carrolee ; et al.	2007-04-05
Neurogenesis By Muscarinic Receptor Modulation App 20070049576 - Barlow; Carrolee ; et al.	2007-03-01
Methods for identifying agents and conditions that modulate neurogenesis App 20070015138 - Barlow; Carrolee ; et al.	2007-01-18
Microelectronic arrays for cell-based functional genomics/ high throughput phenotyping by electrokinetic assembly App 20050173249 - Barlow, Carrolee ; et al.	2005-08-11
System and method for analyzing gene expression data App 20030194711 - Zapala, Matthew ; et al.	2003-10-16
Transgenic animals at a nuclear hormone receptor locus App 20020133837 - Barlow, Carrolee ; et al.	2002-09-19

Company Registrations

SEC

0001745316

Barlow Carrolee

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.